-
All Resources
(choose a category)
-
All Resources
-
selected
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Caring for older people
- Dermatology
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Health service organisation and delivery
- Infectious disease
- Injuries, accidents and wounds
- Learning disability
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Paediatrics
- Palliative care
- Patient experience
- Physical disability
- Public health
- Respiratory system
- Resource Type
- Programme
- Year
49 results found filtered by Evidence Remove Evidence Filter 2011 Remove 2011 Filter 2010 Remove 2010 Filter 2005 Remove 2005 Filter Clear Search
-
Appraisal Guidance No 229 – Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal
- Published
- 27 July 2011
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 232 – Retigabine for the adjunctive treatment of partial onset seizures in epilepsy
- Published
- 27 July 2011
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 230 – Bivalirudin for the treatment of ST-segment-elevation myocardial infarction
- Published
- 27 July 2011
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 228 – Bortezomib and thalidomide for the first-line treatment of multiple myeloma
- Published
- 27 July 2011
- Cycle of Improvement
- Evidence
-
Standards for Human Immunodeficiency Virus (HIV) Services
- Published
- 18 July 2011
- Cycle of Improvement
- Evidence
-
Standards for ICPs - child and adolescent services
- Published
- 30 June 2011
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 227 – Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer
- Published
- 29 June 2011
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 225
- Published
- 22 June 2011
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 226 – Rituximab for the first-line maintenance treatment of follicular non-Hodgkin’s lymphoma
- Published
- 22 June 2011
- Cycle of Improvement
- Evidence
-
Orthopaedic spinal surgery for mechanical low back pain or degenerative spondylolisthesis: evidence note 36
- Published
- 27 May 2011
- Cycle of Improvement
- Evidence